Showing results (1611-1620 of 1,955) with videos related to
Sort By:
Pageof 196
Cancer Chemotherapy and Pharmacology|March 3, 2012
An open-label, phase 1 study evaluating safety, tolerability, and pharmacokinetics of linifanib (ABT-869) in Japanese patients with solid tumorsHajime Asahina, Yosuke Tamura, Hiroshi Nokihara, et al.Nature Chemical Biology|September 25, 2019
The morphogen Sonic hedgehog inhibits its receptor Patched by a pincer grasp mechanismAmalie F Rudolf, Maia Kinnebrew, Christiane Kowatsch, et al.Blood Advances|February 18, 2025
Comparison of outcomes in postinduction strategies for primary central nervous system lymphoma: a Mayo Clinic experienceSteven R Hwang, Richard C Godby, Brianna J Negaard, et al.Msystems|May 8, 2024
Ectomycorrhizal fungi alter soil food webs and the functional potential of bacterial communitiesLouis Berrios, Glade D Bogar, Laura M Bogar, et al.The Journal of Clinical Psychiatry|February 8, 2011
Self-harm subscale of the Schedule for Nonadaptive and Adaptive Personality (SNAP): predicting suicide attempts over 8 years of follow-upShirley Yen, M Tracie Shea, Zach Walsh, et al.Journal of the National Cancer Institute. Monographs|September 1, 2014
Medical history, lifestyle, family history, and occupational risk factors for peripheral T-cell lymphomas: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectSophia S Wang, Christopher R Flowers, Marshall E Kadin, et al.JAMA|October 29, 2009
Cardiovascular and noncardiovascular mortality among patients starting dialysisDinanda J de Jager, Diana C Grootendorst, Kitty J Jager, et al.Journal of Applied Microbiology|August 26, 2019
Developments in understanding and applying prebiotics in research and practice-an ISAPP conference paperK P Scott, R Grimaldi, M Cunningham, et al.Journal of Thrombosis and Thrombolysis|July 28, 2018
Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registryLarry R Jackson, Sunghee Kim, Peter Shrader, et al.British Journal of Haematology|August 7, 2018
Targeting CD38 with daratumumab is lethal to Waldenström macroglobulinaemia cellsAneel Paulus, Alak Manna, Sharoon Akhtar, et al.Pageof 196